These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39416768)

  • 1. IL-15-induced CD38
    Fan J; Xu M; Liu K; Yan W; Wu H; Dong H; Yang Y; Ye W
    Clin Transl Immunology; 2024; 13(10):e70007. PubMed ID: 39416768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate-like bystander-activated CD38
    Huang CH; Fan JH; Jeng WJ; Chang ST; Yang CK; Teng W; Wu TH; Hsieh YC; Chen WT; Chen YC; Sheen IS; Lin YC; Lin CY
    Hepatology; 2022 Sep; 76(3):803-818. PubMed ID: 35060158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent High Percentage of HLA-DR
    Du J; Wei L; Li G; Hua M; Sun Y; Wang D; Han K; Yan Y; Song C; Song R; Zhang H; Han J; Liu J; Kong Y
    Front Immunol; 2021; 12():735125. PubMed ID: 34567001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Change of Effector Tumor-Infiltrating CCR5
    Chen PY; Wu CY; Fang JH; Chen HC; Feng LY; Huang CY; Wei KC; Fang JY; Lin CY
    Front Immunol; 2019; 10():2395. PubMed ID: 31649684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8
    Lebossé F; Gudd C; Tunc E; Singanayagam A; Nathwani R; Triantafyllou E; Pop O; Kumar N; Mukherjee S; Hou TZ; Quaglia A; Zoulim F; Wendon J; Dhar A; Thursz M; Antoniades CG; Khamri W
    EBioMedicine; 2019 Nov; 49():258-268. PubMed ID: 31678004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers.
    Hua S; Lécuroux C; Sáez-Cirión A; Pancino G; Girault I; Versmisse P; Boufassa F; Taulera O; Sinet M; Lambotte O; Venet A
    PLoS One; 2014; 9(7):e101920. PubMed ID: 25000587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D modulates the expression of HLA-DR and CD38 after in vitro activation of T-cells.
    Villegas-Ospina S; Aguilar-Jimenez W; Gonzalez SM; Rugeles MT
    Horm Mol Biol Clin Investig; 2017 Mar; 29(3):93-103. PubMed ID: 28222027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of HLA-DR
    Nguyen TH; Kumar D; Prince C; Martini D; Grunwell JR; Lawrence T; Whitely T; Chappelle K; Chonat S; Prahalad S; Briones M; Chandrakasan S
    J Allergy Clin Immunol; 2024 Jan; 153(1):309-319. PubMed ID: 37517575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.
    Chandele A; Sewatanon J; Gunisetty S; Singla M; Onlamoon N; Akondy RS; Kissick HT; Nayak K; Reddy ES; Kalam H; Kumar D; Verma A; Panda H; Wang S; Angkasekwinai N; Pattanapanyasat K; Chokephaibulkit K; Medigeshi GR; Lodha R; Kabra S; Ahmed R; Murali-Krishna K
    J Virol; 2016 Dec; 90(24):11259-11278. PubMed ID: 27707928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human liver CD8
    Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC
    J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-Resident Bystander CD8
    Kefalakes H; Horgan XJ; Jung MK; Amanakis G; Kapuria D; Bolte FJ; Kleiner DE; Koh C; Heller T; Rehermann B
    Gastroenterology; 2021 Nov; 161(5):1567-1583.e9. PubMed ID: 34302839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonally diverse CD38
    Wang Z; Zhu L; Nguyen THO; Wan Y; Sant S; Quiñones-Parra SM; Crawford JC; Eltahla AA; Rizzetto S; Bull RA; Qiu C; Koutsakos M; Clemens EB; Loh L; Chen T; Liu L; Cao P; Ren Y; Kedzierski L; Kotsimbos T; McCaw JM; La Gruta NL; Turner SJ; Cheng AC; Luciani F; Zhang X; Doherty PC; Thomas PG; Xu J; Kedzierska K
    Nat Commun; 2018 Feb; 9(1):824. PubMed ID: 29483513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate-like Cytotoxic Function of Bystander-Activated CD8
    Kim J; Chang DY; Lee HW; Lee H; Kim JH; Sung PS; Kim KH; Hong SH; Kang W; Lee J; Shin SY; Yu HT; You S; Choi YS; Oh I; Lee DH; Lee DH; Jung MK; Suh KS; Hwang S; Kim W; Park SH; Kim HJ; Shin EC
    Immunity; 2018 Jan; 48(1):161-173.e5. PubMed ID: 29305140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The correlation between HLA-DR or CD38 expression in CD8(+)T cells and CD4(+)T cells count in treatment-naive HIV/AIDS patients].
    Xie J; Qiu Z; Han Y; Li Y; Song X; Li T
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):36-9. PubMed ID: 26796651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of CD38 and HLA-DR on CD8+ T cells in pediatric AIDS patients receiving highly active antiretroviral therapy (HAART)].
    Jin CZ; Feng L; Xie TS; Wu LJ; Fang MX; Zhang FJ; Zhao Y; Wu NP
    Zhonghua Er Ke Za Zhi; 2011 Jan; 49(1):49-52. PubMed ID: 21429312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8
    Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
    Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-expression of CD8
    Zuluaga P; Sanvisens A; Martínez-Cáceres E; Teniente A; Tor J; Muga R
    Drug Alcohol Depend; 2017 Nov; 180():7-13. PubMed ID: 28850904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD38
    Khandelwal P; Chaturvedi V; Owsley E; Lane A; Heyenbruch D; Lutzko CM; Leemhuis T; Grimley MS; Nelson AS; Davies SM; Jordan MB; Marsh RA
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):1-6. PubMed ID: 31442594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fuzhengpaidu granule regulates immune activation molecules CD38 and human leukocyte antigen-D related on CD4+ and CD8+ T cells in patients with acquired immunodeficiency syndrome/human immunodeficiency virus.
    Jiang F; Zhang R; Gu Z; Zhang H; Guo H; Deng X; Liang J
    J Tradit Chin Med; 2013 Aug; 33(4):439-43. PubMed ID: 24187862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.